 |
인쇄하기
취소
|
ARB drugs surpass calcium antagonists
The market share of angiotensin-2 receptor blocks (ARB), such as Almetec and Cozzar, has gained momentum, outpacing the former No. 1 drug on the antihypertensive market, Norvasc, by a wide margin.
ARB drugs accounted for about 50 percent, to 836.8 billion won in domestic 1.5 trillion won market in 2010.
The No. 2 player, calcium antagonists, recorded 468.1 billion won in last year’s reven...
ARB drugs accounted for about 50 percent, to 836.8 billion won in domestic 1.5 trillion won market in 2010.
The No. 2 player, calcium antagonists, recorded 468.1 billion won in last year’s reven...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.